Agenda.
Thursday 28th April 2022
1255 - 1300
Welcome Address
Mr Kiaran O’Malley
President, Irish Society of Urology
1300 - 1320
Men Undergoing Prostatectomy for Prostate Cancer: A Narrative Inquiry
Dr Melissa Corbally
Dublin City University
Chair: Dr Sharon Glynn, NUI Galway & Mr David Galvin, St Vincent’s University Hospital, Dublin
1320 - 1340
Genomic Testing, Biomarkers & Their Clinical Applications
Mr Peter Lonergan
St James’s Hospital, Dublin
1340 - 1400
Role of MRI in the Pre-treatment Evaluation of Prostate Cancer
Dr Sungmin Woo
Memorial Sloan Kettering, New York
1400 - 1420
Transperineal Biopsy
Dr Michelle McNicholas
Mater Misericordiae University Hospital, Dublin
1420 - 1440
Pathology Challenges of Active Surveillance
Dr Susan Prendeville
University Health Network, Toronto
1440 - 1530
Tumour Board – Diagnostic Dilemmas
Chair: Mr Robert Flynn, Tallaght University Hospital, Dublin
Dr Alexandre Zlotta
University of Toronto
Mr Peter Lonergan
St James’s Hospital, Dublin
Prof Frank Sullivan
Galway Clinic
Dr Sungmin Woo
Memorial Sloan Kettering, New York
1530 - 1600
Coffee Break
Chairs: Mr Paul Sweeney, Mercy University Hospital Cork
1600 - 1620
Molecular Classification in Muscle Invasive Bladder Cancer
Prof Yves Allory
Institut Curie, Paris
1620 - 1640
Vesical Imaging-Reporting & Data System
Dr Jeeban Das
Memorial Sloan Kettering Cancer Centre, New York
1640 - 1700
Trimodal Therapy
Dr Alexandre Zlotta
University of Toronto
1700 - 1720
Radiotherapy
Prof Ananya Choudhury
The Christie NHS Foundation Trust, Manchester
1720 - 1740
Immunotherapy
Prof Tom Powles
St Bart’s Hospital, London
1740 - 1830
Bladder Case Discussions
Chair: Mr Gregory Nason, Mater Misericordiae University Hospital, Dublin
Prof Yves Allory
Institut Curie, Paris
Dr Jeeban Das
Memorial Sloan Kettering, New York
Dr Alexandre Zlotta
University of Toronto
Prof Tom Powles
St Bart’s Hospital, London
1830
End of Day 1
Friday 29th April 2022
Chairs: Dr Ciara Lyons, Cork University Hospital & Mr Hugh O’Kane, Belfast City Hospital
0830 - 0850
Assessment of Pathological Parameters of High-Grade Prostate Cancer
Dr Susan Prendeville
University Health Network, Toronto
0850 - 0910
PSMA Radiotheranostics
Dr Heiko Schoder
Memorial Sloan Kettering Cancer Centre, New York
0910 - 0930
Triple Therapy in High-Risk Prostate Cancer
Dr Daniel Spratt
University Hospitals Seidman Cancer Centre, Cleveland
0930 - 0950
Low Volume Metastatic Prostate Cancer
Prof Karim Fizazi
Gustave Roussy Institute, Paris
0950 - 1010
Is Retzius-Sparing RARP a Reasonable Surgical Approach for High Risk Prostate Cancer
Prof Christopher Eden
Royal Surrey County Hospital, Guildford
1010 - 1045
Coffee Break
Chairs: Ms Anna Walsh, St George’s Hospital, London & Dr John Moriarty, Mater Misericordiae University Hospital, Dublin
1045 –1105
Radiology - Challenges of Diagnosis
Dr Martin O’Malley
University of Toronto
1105 - 1125
Molecular Aspects of Renal Tumours
Dr Lisa Browning
John Radcliffe Hospital, Oxford
1125 - 1145
Small Renal Masses, Biopsy, Surveillance & Management
Dr Tony Finelli
Princess Margaret Cancer Centre, Toronto
1145 - 1205
Renal Tumour Cryoablation
Dr Umer Salati
Mater Misericordiae University Hospital, Dublin
1205 - 1225
Renal SBRT
Prof Shankar Siva
Peter MacCallum Cancer Centre, Melbourne
1225 –1245
Chartering New Pathways in Adjuvant Therapy for Renal Cancer
Dr Toni Choueiri
Dana-Farber Cancer Institute, Boston
1245 - 1335
Renal Panel Discussion
Chair: Prof Ray McDermott, St Vincent’s University Hospital, Dublin
Dr Tony Finelli
Princess Margaret Cancer Centre, Toronto
Dr Umer Salati
Mater Misericordiae University Hospital, Dublin
Prof Shankar Siva
Peter MacCallum Cancer Centre, Melbourne
Dr Toni Choueiri
Dana-Farber Cancer Institute, Boston
1335 - 1430
Lunch
Chairs: Dr Miriam O’Connor, University Hospital Waterford & Dr Daniel Cagney, Mater Private Hospital, Dublin
1430 - 1450
Is There A Role For Surgery In Metastatic Prostate Cancer?
Dr Tony Finelli
Princess Margaret Cancer Centre, Toronto
1450 - 1510
Role of Radiation to The Prostate Primary in Metastatic Disease
Dr Daniel Spratt
University Hospitals Seidman Cancer Centre, Cleveland
1510 - 1530
SBRT for Oligometastatic Disease
Prof Shankar Siva
Peter MacCallum Cancer Centre, Melbourne
1530 - 1550
Systemic Therapy for Oligometastatic Disease
Dr Richard Bambury
Cork University Hospital
1550 - 1600
Comfort Break
1600 - 1650
Prostate Panel Discussion
Chair: Dr Aidan Cole, Queen's University, Belfast
Dr Tony Finelli
Princess Margaret Cancer Centre, Toronto
Dr Paul Kelly
Bon Secours Hospital, Cork
Prof Shankar Siva
Peter MacCallum Cancer Centre, Melbourne
Dr Richard Bambury
Cork University Hospital
1650
End of Proceedings